Ultrasound Versus Virtual Reality on Temporomandibular Disorder

May 4, 2026 updated by: Amany Refaat Mohamed Abdel Wahid

Ultrasound Versus Virtual Reality on Temporomandibular Disorder Following Surgical Tooth Extraction

The Purpose of the study is to compare between the therapeutic efficacy of ultrasound and VR in decreasing pain and improving ROM for Patients with temporomandibular joint disorder after tooth extraction surgery.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study will be carried out on patients suffering from temporomandibular joint disorder following tooth extraction surgery. Their ages will range from (40-60) years. They will be randomly divided into two equal groups:

  1. Group A:

    This group will include 25 patients suffering from TMJ dysfunction (pain and reduced mouth opening) after tooth extraction. They will receive pulsed ultrasound and traditional manual therapy. The first session of treatment will be 24hr after extraction for three times for one week.

  2. Group B:

This group will include 25 patients suffering from TMJ dysfunction (pain and reduced mouth opening) after tooth extraction. They will receive virtual reality and traditional manual therapy. The first session of treatment will be 24hr after extraction for three times for one week.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The subject selection will be according to the following criteria:

    • Patients after tooth extraction.
    • Patients from both genders.
    • Patients suffering from pain and reduced mouth opening.
    • Age ranges between 40-60 years.
    • All patients will have informed consent.

Exclusion Criteria:

  • . Surgery that conducted on the temporomandibular joint (meniscectomy, arthroscopy, etc.).

    • Patients with systemic disease as diabetes mellitus.
    • Patients with neurological conditions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: group who will receive ultrasound
They will receive pulsed ultrasound and traditional manual therapy.
Device: ultrasound
pulsed ultrasound
Active Comparator: group who will receive virtual reality
they will receive virtual reality and traditional manual therapy.
Device: virtual reality
Fully Immersive VR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain free maximum mouth opening (MMO)
Time Frame: before and after the treatment (after 1 week)
Millimeter ruler for measuring pain free maximum mouth opening (MMO)
before and after the treatment (after 1 week)
pain measurement
Time Frame: before and after the treatment ( 1 week)
Visual Analogue Scale for pain measurement (VAS).
before and after the treatment ( 1 week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Amany Refaat Mohamed Abdel Wahid

Collaborators

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 4, 2026

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

May 4, 2026

First Submitted That Met QC Criteria

May 4, 2026

First Posted (Actual)

May 8, 2026

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 4, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.TREC/012/006341

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Disorders (TMD)

Clinical Trials on ultrasound

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe